Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Fairfield Market Research | PRODUCT CODE: 1940985

Cover Image

PUBLISHER: Fairfield Market Research | PRODUCT CODE: 1940985

Neurovascular Devices Market Insights, Competitive Landscape, and Market Forecast - 2033

PUBLISHED:
PAGES: 197 Pages
DELIVERY TIME: 2-5 business days
SELECT AN OPTION
Unprintable PDF & Excel (Single User License)
USD 4995
Unprintable PDF & Excel (Multi User License upto 5 users)
USD 8495
Printable PDF & Excel (Enterprise License above 5 users)
USD 10600

Add to Cart

The global Neurovascular Devices Market is set for significant growth, with an estimated value of USD 4.4 billion in 2026, projected to reach USD 8.6 billion by 2033, representing a robust CAGR of 10.0% during the forecast period. Neurovascular devices are advanced medical instruments designed to diagnose, treat, and manage cerebrovascular disorders, including brain aneurysms, ischemic strokes, stenosis, and other vascular abnormalities. These devices are critical in delivering minimally invasive solutions, reducing procedural risks, and improving patient outcomes.

The market's expansion is driven by increasing prevalence of neurological disorders, rising awareness of advanced treatment options, and continuous technological innovations in neurovascular devices. As healthcare facilities such as hospitals, clinics, and ambulatory surgical centers increasingly adopt these solutions, the demand for neurovascular devices continues to rise, presenting a lucrative landscape for manufacturers and investors.

Market Insights

The Neurovascular Devices Market is characterized by rapid technological evolution, with products such as flow diverters, stent retrievers, embolic coils, and neurothrombectomy devices transforming the management of cerebrovascular conditions. These devices are gaining preference due to their precision, efficacy, and reduced invasiveness compared to traditional surgical methods.

The increasing incidence of strokes and other neurovascular disorders, particularly in aging populations, is a key factor driving market demand. Globally, strokes are a leading cause of mortality and long-term disability, emphasizing the need for effective neurovascular interventions. Furthermore, rising investments in healthcare infrastructure, especially in developing regions, are enhancing access to neurovascular devices, fueling growth in markets such as Asia Pacific, Latin America, and the Middle East & Africa (LAMEA).

Market Drivers

Several factors are propelling the Neurovascular Devices Market:

  • 1. Rising Incidence of Neurological Disorders: Increased cases of stroke, brain aneurysms, and vascular stenosis are driving demand for innovative treatment solutions.
  • 2. Technological Advancements: Development of devices such as flow diverters, intrasaccular devices, and stent retrievers offers minimally invasive procedures with improved patient safety and recovery.
  • 3. Aging Population: The global increase in geriatric population contributes to higher prevalence of cerebrovascular diseases, boosting device demand.
  • 4. Government Initiatives and Healthcare Spending: Increased investments in healthcare infrastructure and supportive policies are promoting adoption of advanced neurovascular devices.
  • 5. Growing Awareness and Early Diagnosis: Improved awareness campaigns and diagnostic capabilities are leading to early intervention, increasing the utilization of neurovascular devices.

Business Opportunities

The market offers multiple growth opportunities for both established players and new entrants. Companies are investing in research and development to introduce innovative, patient-centric devices. Collaboration with hospitals, research institutions, and technology providers is enabling the development of next-generation solutions with enhanced precision, safety, and procedural efficiency.

Emerging markets are particularly promising due to the rising incidence of neurovascular disorders and the expansion of healthcare infrastructure. Strategic partnerships, mergers, and acquisitions are expected to accelerate market penetration and technological advancement. Companies focusing on minimally invasive solutions and customized patient care are poised to gain a competitive advantage in this evolving market.

Regional Analysis

  • North America: Holds a dominant position due to advanced healthcare infrastructure, high adoption of innovative devices, and presence of key market leaders.
  • Europe: Exhibits steady growth, driven by technological innovation, supportive government initiatives, and increasing prevalence of neurovascular conditions.
  • Asia Pacific: Expected to witness rapid growth due to rising healthcare investments, expanding hospital infrastructure, and increasing awareness of neurovascular disorders.
  • LAMEA: Shows gradual expansion, fueled by improvements in healthcare facilities and rising diagnosis rates for neurological diseases.

Key Players

The Neurovascular Devices Market is highly competitive, with leading players investing in innovation, strategic partnerships, and market expansion. Key market participants include:

  • Medtronic plc
  • Stryker Corporation
  • Abbott Laboratories
  • Boston Scientific Corporation
  • Terumo Corporation
  • Penumbra, Inc.
  • Johnson & Johnson (DePuy Synthes)
  • MicroPort Scientific Corporation
  • Cook Medical
  • Siemens Healthineers
  • GE Healthcare
  • Philips Healthcare
  • Rapid Medical Ltd.
  • Insera Therapeutics (Raymond Neurovascular)
  • Ruehi Medical Ltd.

These companies are focused on delivering technologically advanced solutions, enhancing procedural efficiency, and expanding regional presence to strengthen market leadership.

Market Segmentation

By Product:

  • Embolic Coils
  • Carotid Stents
  • Intracranial Stents
  • Catheters
  • Embolic Protection Devices
  • Flow Diverters
  • Neurothrombectomy Devices
  • Intrasaccular Devices
  • Balloon Systems
  • Stent Retrievers
  • Guidewires
  • Others

By Therapeutic Application:

  • Brain Aneurysm
  • Stenosis
  • Ischemic Strokes
  • Others

By Process:

  • Neurothrombectomy Procedure
  • Cerebral Angiography Technique
  • Carotid Endarterectomy (CEA)
  • Stenting
  • Microsurgical Clipping
  • Coiling
  • Flow Diversion
  • Others

By End-user:

  • Hospitals
  • Ambulatory Surgical Centers
  • Clinics
  • Others

By Region:

  • North America
  • Europe
  • Asia Pacific
  • LAMEA

Table of Contents

1. Executive Summary

  • 1.1. Global Neurovascular Devices Market Snapshot
  • 1.2. Future Projections
  • 1.3. Key Market Trends
  • 1.4. Regional Snapshot, by Value, 2026
  • 1.5. Analyst Recommendations

2. Market Overview

  • 2.1. Market Definitions and Segmentations
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Market Opportunities
  • 2.3. Value Chain Analysis
  • 2.4. COVID-19 Impact Analysis
  • 2.5. Porter's Fiver Forces Analysis
  • 2.6. Impact of Russia-Ukraine Conflict
  • 2.7. PESTLE Analysis
  • 2.8. Regulatory Analysis
  • 2.9. Price Trend Analysis
    • 2.9.1. Current Prices and Future Projections, 2025-2033
    • 2.9.2. Price Impact Factors

3. Global Neurovascular Devices Market Outlook, 2020-2033

  • 3.1. Global Neurovascular Devices Market Outlook, by Product, Value (US$ Bn), 2020-2033
    • 3.1.1. Embolic Coils
    • 3.1.2. Carotid Stents
    • 3.1.3. Intracranial Stents
    • 3.1.4. Catheters
    • 3.1.5. Embolic Protection Devices
    • 3.1.6. Flow Diverters
    • 3.1.7. Neurothrombectomy Devices
    • 3.1.8. Intrasaccular Devices
    • 3.1.9. Balloon Systems
    • 3.1.10. Stent Retrievers
  • 3.2. Global Neurovascular Devices Market Outlook, by Therapeutic Application, Value (US$ Bn), 2020-2033
    • 3.2.1. Brain Aneurysm
    • 3.2.2. Stenosis
    • 3.2.3. Ischemic Strokes
    • 3.2.4. Others
  • 3.3. Global Neurovascular Devices Market Outlook, by Process, Value (US$ Bn), 2020-2033
    • 3.3.1. Neurothrombectomy Procedure
    • 3.3.2. Cerebral Angiography Technique
    • 3.3.3. Carotid Endarterectomy (CEA)
    • 3.3.4. Stenting
    • 3.3.5. Microsurgical Clipping
    • 3.3.6. Coiling
    • 3.3.7. Flow Diversion
    • 3.3.8. Others
  • 3.4. Global Neurovascular Devices Market Outlook, by End-user, Value (US$ Bn), 2020-2033
    • 3.4.1. Hospitals
    • 3.4.2. Ambulatory Surgical Centers
    • 3.4.3. Clinics
    • 3.4.4. Others
  • 3.5. Global Neurovascular Devices Market Outlook, by Region, Value (US$ Bn), 2020-2033
    • 3.5.1. North America
    • 3.5.2. Europe
    • 3.5.3. Asia Pacific
    • 3.5.4. Latin America
    • 3.5.5. Middle East & Africa

4. North America Neurovascular Devices Market Outlook, 2020-2033

  • 4.1. North America Neurovascular Devices Market Outlook, by Product, Value (US$ Bn), 2020-2033
    • 4.1.1. Embolic Coils
    • 4.1.2. Carotid Stents
    • 4.1.3. Intracranial Stents
    • 4.1.4. Catheters
    • 4.1.5. Embolic Protection Devices
    • 4.1.6. Flow Diverters
    • 4.1.7. Neurothrombectomy Devices
    • 4.1.8. Intrasaccular Devices
    • 4.1.9. Balloon Systems
    • 4.1.10. Stent Retrievers
  • 4.2. North America Neurovascular Devices Market Outlook, by Therapeutic Application, Value (US$ Bn), 2020-2033
    • 4.2.1. Brain Aneurysm
    • 4.2.2. Stenosis
    • 4.2.3. Ischemic Strokes
    • 4.2.4. Others
  • 4.3. North America Neurovascular Devices Market Outlook, by Process, Value (US$ Bn), 2020-2033
    • 4.3.1. Neurothrombectomy Procedure
    • 4.3.2. Cerebral Angiography Technique
    • 4.3.3. Carotid Endarterectomy (CEA)
    • 4.3.4. Stenting
    • 4.3.5. Microsurgical Clipping
    • 4.3.6. Coiling
    • 4.3.7. Flow Diversion
    • 4.3.8. Others
  • 4.4. North America Neurovascular Devices Market Outlook, by End-user, Value (US$ Bn), 2020-2033
    • 4.4.1. Hospitals
    • 4.4.2. Ambulatory Surgical Centers
    • 4.4.3. Clinics
    • 4.4.4. Others
  • 4.5. North America Neurovascular Devices Market Outlook, by Country, Value (US$ Bn), 2020-2033
    • 4.5.1. U.S. Neurovascular Devices Market Outlook, by Product, 2020-2033
    • 4.5.2. U.S. Neurovascular Devices Market Outlook, by Therapeutic Application, 2020-2033
    • 4.5.3. U.S. Neurovascular Devices Market Outlook, by Process, 2020-2033
    • 4.5.4. U.S. Neurovascular Devices Market Outlook, by End-user, 2020-2033
    • 4.5.5. Canada Neurovascular Devices Market Outlook, by Product, 2020-2033
    • 4.5.6. Canada Neurovascular Devices Market Outlook, by Therapeutic Application, 2020-2033
    • 4.5.7. Canada Neurovascular Devices Market Outlook, by Process, 2020-2033
    • 4.5.8. Canada Neurovascular Devices Market Outlook, by End-user, 2020-2033
  • 4.6. BPS Analysis/Market Attractiveness Analysis

5. Europe Neurovascular Devices Market Outlook, 2020-2033

  • 5.1. Europe Neurovascular Devices Market Outlook, by Product, Value (US$ Bn), 2020-2033
    • 5.1.1. Embolic Coils
    • 5.1.2. Carotid Stents
    • 5.1.3. Intracranial Stents
    • 5.1.4. Catheters
    • 5.1.5. Embolic Protection Devices
    • 5.1.6. Flow Diverters
    • 5.1.7. Neurothrombectomy Devices
    • 5.1.8. Intrasaccular Devices
    • 5.1.9. Balloon Systems
    • 5.1.10. Stent Retrievers
  • 5.2. Europe Neurovascular Devices Market Outlook, by Therapeutic Application, Value (US$ Bn), 2020-2033
    • 5.2.1. Brain Aneurysm
    • 5.2.2. Stenosis
    • 5.2.3. Ischemic Strokes
    • 5.2.4. Others
  • 5.3. Europe Neurovascular Devices Market Outlook, by Process, Value (US$ Bn), 2020-2033
    • 5.3.1. Neurothrombectomy Procedure
    • 5.3.2. Cerebral Angiography Technique
    • 5.3.3. Carotid Endarterectomy (CEA)
    • 5.3.4. Stenting
    • 5.3.5. Microsurgical Clipping
    • 5.3.6. Coiling
    • 5.3.7. Flow Diversion
    • 5.3.8. Others
  • 5.4. Europe Neurovascular Devices Market Outlook, by End-user, Value (US$ Bn), 2020-2033
    • 5.4.1. Hospitals
    • 5.4.2. Ambulatory Surgical Centers
    • 5.4.3. Clinics
    • 5.4.4. Others
  • 5.5. Europe Neurovascular Devices Market Outlook, by Country, Value (US$ Bn), 2020-2033
    • 5.5.1. Germany Neurovascular Devices Market Outlook, by Product, 2020-2033
    • 5.5.2. Germany Neurovascular Devices Market Outlook, by Therapeutic Application, 2020-2033
    • 5.5.3. Germany Neurovascular Devices Market Outlook, by Process, 2020-2033
    • 5.5.4. Germany Neurovascular Devices Market Outlook, by End-user, 2020-2033
    • 5.5.5. Italy Neurovascular Devices Market Outlook, by Product, 2020-2033
    • 5.5.6. Italy Neurovascular Devices Market Outlook, by Therapeutic Application, 2020-2033
    • 5.5.7. Italy Neurovascular Devices Market Outlook, by Process, 2020-2033
    • 5.5.8. Italy Neurovascular Devices Market Outlook, by End-user, 2020-2033
    • 5.5.9. France Neurovascular Devices Market Outlook, by Product, 2020-2033
    • 5.5.10. France Neurovascular Devices Market Outlook, by Therapeutic Application, 2020-2033
    • 5.5.11. France Neurovascular Devices Market Outlook, by Process, 2020-2033
    • 5.5.12. France Neurovascular Devices Market Outlook, by End-user, 2020-2033
    • 5.5.13. U.K. Neurovascular Devices Market Outlook, by Product, 2020-2033
    • 5.5.14. U.K. Neurovascular Devices Market Outlook, by Therapeutic Application, 2020-2033
    • 5.5.15. U.K. Neurovascular Devices Market Outlook, by Process, 2020-2033
    • 5.5.16. U.K. Neurovascular Devices Market Outlook, by End-user, 2020-2033
    • 5.5.17. Spain Neurovascular Devices Market Outlook, by Product, 2020-2033
    • 5.5.18. Spain Neurovascular Devices Market Outlook, by Therapeutic Application, 2020-2033
    • 5.5.19. Spain Neurovascular Devices Market Outlook, by Process, 2020-2033
    • 5.5.20. Spain Neurovascular Devices Market Outlook, by End-user, 2020-2033
    • 5.5.21. Russia Neurovascular Devices Market Outlook, by Product, 2020-2033
    • 5.5.22. Russia Neurovascular Devices Market Outlook, by Therapeutic Application, 2020-2033
    • 5.5.23. Russia Neurovascular Devices Market Outlook, by Process, 2020-2033
    • 5.5.24. Russia Neurovascular Devices Market Outlook, by End-user, 2020-2033
    • 5.5.25. Rest of Europe Neurovascular Devices Market Outlook, by Product, 2020-2033
    • 5.5.26. Rest of Europe Neurovascular Devices Market Outlook, by Therapeutic Application, 2020-2033
    • 5.5.27. Rest of Europe Neurovascular Devices Market Outlook, by Process, 2020-2033
    • 5.5.28. Rest of Europe Neurovascular Devices Market Outlook, by End-user, 2020-2033
  • 5.6. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Neurovascular Devices Market Outlook, 2020-2033

  • 6.1. Asia Pacific Neurovascular Devices Market Outlook, by Product, Value (US$ Bn), 2020-2033
    • 6.1.1. Embolic Coils
    • 6.1.2. Carotid Stents
    • 6.1.3. Intracranial Stents
    • 6.1.4. Catheters
    • 6.1.5. Embolic Protection Devices
    • 6.1.6. Flow Diverters
    • 6.1.7. Neurothrombectomy Devices
    • 6.1.8. Intrasaccular Devices
    • 6.1.9. Balloon Systems
    • 6.1.10. Stent Retrievers
  • 6.2. Asia Pacific Neurovascular Devices Market Outlook, by Therapeutic Application, Value (US$ Bn), 2020-2033
    • 6.2.1. Brain Aneurysm
    • 6.2.2. Stenosis
    • 6.2.3. Ischemic Strokes
    • 6.2.4. Others
  • 6.3. Asia Pacific Neurovascular Devices Market Outlook, by Process, Value (US$ Bn), 2020-2033
    • 6.3.1. Neurothrombectomy Procedure
    • 6.3.2. Cerebral Angiography Technique
    • 6.3.3. Carotid Endarterectomy (CEA)
    • 6.3.4. Stenting
    • 6.3.5. Microsurgical Clipping
    • 6.3.6. Coiling
    • 6.3.7. Flow Diversion
    • 6.3.8. Others
  • 6.4. Asia Pacific Neurovascular Devices Market Outlook, by End-user, Value (US$ Bn), 2020-2033
    • 6.4.1. Hospitals
    • 6.4.2. Ambulatory Surgical Centers
    • 6.4.3. Clinics
    • 6.4.4. Others
  • 6.5. Asia Pacific Neurovascular Devices Market Outlook, by Country, Value (US$ Bn), 2020-2033
    • 6.5.1. China Neurovascular Devices Market Outlook, by Product, 2020-2033
    • 6.5.2. China Neurovascular Devices Market Outlook, by Therapeutic Application, 2020-2033
    • 6.5.3. China Neurovascular Devices Market Outlook, by Process, 2020-2033
    • 6.5.4. China Neurovascular Devices Market Outlook, by End-user, 2020-2033
    • 6.5.5. Japan Neurovascular Devices Market Outlook, by Product, 2020-2033
    • 6.5.6. Japan Neurovascular Devices Market Outlook, by Therapeutic Application, 2020-2033
    • 6.5.7. Japan Neurovascular Devices Market Outlook, by Process, 2020-2033
    • 6.5.8. Japan Neurovascular Devices Market Outlook, by End-user, 2020-2033
    • 6.5.9. South Korea Neurovascular Devices Market Outlook, by Product, 2020-2033
    • 6.5.10. South Korea Neurovascular Devices Market Outlook, by Therapeutic Application, 2020-2033
    • 6.5.11. South Korea Neurovascular Devices Market Outlook, by Process, 2020-2033
    • 6.5.12. South Korea Neurovascular Devices Market Outlook, by End-user, 2020-2033
    • 6.5.13. India Neurovascular Devices Market Outlook, by Product, 2020-2033
    • 6.5.14. India Neurovascular Devices Market Outlook, by Therapeutic Application, 2020-2033
    • 6.5.15. India Neurovascular Devices Market Outlook, by Process, 2020-2033
    • 6.5.16. India Neurovascular Devices Market Outlook, by End-user, 2020-2033
    • 6.5.17. Southeast Asia Neurovascular Devices Market Outlook, by Product, 2020-2033
    • 6.5.18. Southeast Asia Neurovascular Devices Market Outlook, by Therapeutic Application, 2020-2033
    • 6.5.19. Southeast Asia Neurovascular Devices Market Outlook, by Process, 2020-2033
    • 6.5.20. Southeast Asia Neurovascular Devices Market Outlook, by End-user, 2020-2033
    • 6.5.21. Rest of SAO Neurovascular Devices Market Outlook, by Product, 2020-2033
    • 6.5.22. Rest of SAO Neurovascular Devices Market Outlook, by Therapeutic Application, 2020-2033
    • 6.5.23. Rest of SAO Neurovascular Devices Market Outlook, by Process, 2020-2033
    • 6.5.24. Rest of SAO Neurovascular Devices Market Outlook, by End-user, 2020-2033
  • 6.6. BPS Analysis/Market Attractiveness Analysis

7. Latin America Neurovascular Devices Market Outlook, 2020-2033

  • 7.1. Latin America Neurovascular Devices Market Outlook, by Product, Value (US$ Bn), 2020-2033
    • 7.1.1. Embolic Coils
    • 7.1.2. Carotid Stents
    • 7.1.3. Intracranial Stents
    • 7.1.4. Catheters
    • 7.1.5. Embolic Protection Devices
    • 7.1.6. Flow Diverters
    • 7.1.7. Neurothrombectomy Devices
    • 7.1.8. Intrasaccular Devices
    • 7.1.9. Balloon Systems
    • 7.1.10. Stent Retrievers
  • 7.2. Latin America Neurovascular Devices Market Outlook, by Therapeutic Application, Value (US$ Bn), 2020-2033
    • 7.2.1. Brain Aneurysm
    • 7.2.2. Stenosis
    • 7.2.3. Ischemic Strokes
    • 7.2.4. Others
  • 7.3. Latin America Neurovascular Devices Market Outlook, by Process, Value (US$ Bn), 2020-2033
    • 7.3.1. Neurothrombectomy Procedure
    • 7.3.2. Cerebral Angiography Technique
    • 7.3.3. Carotid Endarterectomy (CEA)
    • 7.3.4. Stenting
    • 7.3.5. Microsurgical Clipping
    • 7.3.6. Coiling
    • 7.3.7. Flow Diversion
    • 7.3.8. Others
  • 7.4. Latin America Neurovascular Devices Market Outlook, by End-user, Value (US$ Bn), 2020-2033
    • 7.4.1. Hospitals
    • 7.4.2. Ambulatory Surgical Centers
    • 7.4.3. Clinics
    • 7.4.4. Others
  • 7.5. Latin America Neurovascular Devices Market Outlook, by Country, Value (US$ Bn), 2020-2033
    • 7.5.1. Brazil Neurovascular Devices Market Outlook, by Product, 2020-2033
    • 7.5.2. Brazil Neurovascular Devices Market Outlook, by Therapeutic Application, 2020-2033
    • 7.5.3. Brazil Neurovascular Devices Market Outlook, by Process, 2020-2033
    • 7.5.4. Brazil Neurovascular Devices Market Outlook, by End-user, 2020-2033
    • 7.5.5. Mexico Neurovascular Devices Market Outlook, by Product, 2020-2033
    • 7.5.6. Mexico Neurovascular Devices Market Outlook, by Therapeutic Application, 2020-2033
    • 7.5.7. Mexico Neurovascular Devices Market Outlook, by Process, 2020-2033
    • 7.5.8. Mexico Neurovascular Devices Market Outlook, by End-user, 2020-2033
    • 7.5.9. Argentina Neurovascular Devices Market Outlook, by Product, 2020-2033
    • 7.5.10. Argentina Neurovascular Devices Market Outlook, by Therapeutic Application, 2020-2033
    • 7.5.11. Argentina Neurovascular Devices Market Outlook, by Process, 2020-2033
    • 7.5.12. Argentina Neurovascular Devices Market Outlook, by End-user, 2020-2033
    • 7.5.13. Rest of LATAM Neurovascular Devices Market Outlook, by Product, 2020-2033
    • 7.5.14. Rest of LATAM Neurovascular Devices Market Outlook, by Therapeutic Application, 2020-2033
    • 7.5.15. Rest of LATAM Neurovascular Devices Market Outlook, by Process, 2020-2033
    • 7.5.16. Rest of LATAM Neurovascular Devices Market Outlook, by End-user, 2020-2033
  • 7.6. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Neurovascular Devices Market Outlook, 2020-2033

  • 8.1. Middle East & Africa Neurovascular Devices Market Outlook, by Product, Value (US$ Bn), 2020-2033
    • 8.1.1. Embolic Coils
    • 8.1.2. Carotid Stents
    • 8.1.3. Intracranial Stents
    • 8.1.4. Catheters
    • 8.1.5. Embolic Protection Devices
    • 8.1.6. Flow Diverters
    • 8.1.7. Neurothrombectomy Devices
    • 8.1.8. Intrasaccular Devices
    • 8.1.9. Balloon Systems
    • 8.1.10. Stent Retrievers
  • 8.2. Middle East & Africa Neurovascular Devices Market Outlook, by Therapeutic Application, Value (US$ Bn), 2020-2033
    • 8.2.1. Brain Aneurysm
    • 8.2.2. Stenosis
    • 8.2.3. Ischemic Strokes
    • 8.2.4. Others
  • 8.3. Middle East & Africa Neurovascular Devices Market Outlook, by Process, Value (US$ Bn), 2020-2033
    • 8.3.1. Neurothrombectomy Procedure
    • 8.3.2. Cerebral Angiography Technique
    • 8.3.3. Carotid Endarterectomy (CEA)
    • 8.3.4. Stenting
    • 8.3.5. Microsurgical Clipping
    • 8.3.6. Coiling
    • 8.3.7. Flow Diversion
    • 8.3.8. Others
  • 8.4. Middle East & Africa Neurovascular Devices Market Outlook, by End-user, Value (US$ Bn), 2020-2033
    • 8.4.1. Hospitals
    • 8.4.2. Ambulatory Surgical Centers
    • 8.4.3. Clinics
    • 8.4.4. Others
  • 8.5. Middle East & Africa Neurovascular Devices Market Outlook, by Country, Value (US$ Bn), 2020-2033
    • 8.5.1. GCC Neurovascular Devices Market Outlook, by Product, 2020-2033
    • 8.5.2. GCC Neurovascular Devices Market Outlook, by Therapeutic Application, 2020-2033
    • 8.5.3. GCC Neurovascular Devices Market Outlook, by Process, 2020-2033
    • 8.5.4. GCC Neurovascular Devices Market Outlook, by End-user, 2020-2033
    • 8.5.5. South Africa Neurovascular Devices Market Outlook, by Product, 2020-2033
    • 8.5.6. South Africa Neurovascular Devices Market Outlook, by Therapeutic Application, 2020-2033
    • 8.5.7. South Africa Neurovascular Devices Market Outlook, by Process, 2020-2033
    • 8.5.8. South Africa Neurovascular Devices Market Outlook, by End-user, 2020-2033
    • 8.5.9. Egypt Neurovascular Devices Market Outlook, by Product, 2020-2033
    • 8.5.10. Egypt Neurovascular Devices Market Outlook, by Therapeutic Application, 2020-2033
    • 8.5.11. Egypt Neurovascular Devices Market Outlook, by Process, 2020-2033
    • 8.5.12. Egypt Neurovascular Devices Market Outlook, by End-user, 2020-2033
    • 8.5.13. Nigeria Neurovascular Devices Market Outlook, by Product, 2020-2033
    • 8.5.14. Nigeria Neurovascular Devices Market Outlook, by Therapeutic Application, 2020-2033
    • 8.5.15. Nigeria Neurovascular Devices Market Outlook, by Process, 2020-2033
    • 8.5.16. Nigeria Neurovascular Devices Market Outlook, by End-user, 2020-2033
    • 8.5.17. Rest of Middle East Neurovascular Devices Market Outlook, by Product, 2020-2033
    • 8.5.18. Rest of Middle East Neurovascular Devices Market Outlook, by Therapeutic Application, 2020-2033
    • 8.5.19. Rest of Middle East Neurovascular Devices Market Outlook, by Process, 2020-2033
    • 8.5.20. Rest of Middle East Neurovascular Devices Market Outlook, by End-user, 2020-2033
  • 8.6. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

  • 9.1. Company Vs Segment Heatmap
  • 9.2. Company Market Share Analysis, 2025
  • 9.3. Competitive Dashboard
  • 9.4. Company Profiles
    • 9.4.1. Medtronic plc
      • 9.4.1.1. Company Overview
      • 9.4.1.2. Product Portfolio
      • 9.4.1.3. Financial Overview
      • 9.4.1.4. Business Strategies and Developments
    • 9.4.2. Stryker Corporation
    • 9.4.3. Abbott Laboratories
    • 9.4.4. Boston Scientific Corporation
    • 9.4.5. Terumo Corporation
    • 9.4.6. Penumbra, Inc.
    • 9.4.7. Johnson & Johnson (DePuy Synthes)
    • 9.4.8. MicroPort Scientific Corporation
    • 9.4.9. Cook Medical
    • 9.4.10. Siemens Healthineers

10. Appendix

  • 10.1. Research Methodology
  • 10.2. Report Assumptions
  • 10.3. Acronyms and Abbreviations
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!